Dechra is an international speciality veterinary pharmaceuticals and related products business

Sectors

Pharmaceuticals and Biotechnology
Pharmaceuticals

Disciplines

Consultancy
Creative Direction
Graphic Design
Photography
Printed Annual Report
Online Annual Report
Video Production

Awards

Winner BEST FINANCIAL REPORTING: IR Magazine Awards - Europe
Highly Commended BEST PRINTED REPORT: Corporate and Financial Awards

Background

Dechra recently celebrated 20 years of strategic growth since their incorporation as a company. The progress and success made during this time was the main theme for this year’s report, alongside commentary on how Dechra are well positioned for future growth.

Approach

The front cover and opening fold-out pages showcase a full history timeline and milestones achieved over 20 years, with the fully accessible online version of the report using a clever interactive slider to communicate the journey.

As the only listed veterinary pharmaceuticals company in the FTSE 350, it was important that the content was tailored to investors who maybe aren’t familiar with opportunities and challenges within the market.

Various aspects of the content are displayed in an innovative way, with the business model also featuring a fold out section to ensure that the content is easy to digest and is visually engaging. Taking full advantage of our print specialities, full double page spreads use spot UV, while large images are used to create breakout pages and communicate key case studies.

Questions and answer interviews were held with the Chief Executive Officer and Chief Financial Officer to create engaging and informative narrative. These were featured both within the printed report and as video within the online version.

Outcomes

The 2017 annual report celebrates Dechra's success over 20 years and all that they have achieved. The report is clear and engaging and has been produced both in print and online as a full HTML.

Visit Website Download PDF

Our work

Related projects

Keep up to date

Our latest opinions